title: Management of pulmonary embolism: state of the art treatment and emerging research.
abstract: Pulmonary embolism is one of the most important causes of morbidity and mortality in cardiovascular medicine and demands a circumscribed algorithmic treatment approach (Fig. 1). Anticoagulation should be triggered by a high clinical probability and continued based on urgent definitive imaging. Our assessment then continues with evaluation of the clinical severity of the pulmonary embolism to determine whether the patient will benefit from thrombolysis or not. We usually reserve this option for cases of massive pulmonary embolism (sustained hypotension, pulselessness, or persistent profound bradycardia) or patients with a low cardiopulmonary reserve and categorical signs of right ventricle failure. At this juncture, renal function, a diagnosis of active cancer, calculated bleeding risk, and estimated patient compliance will help us gravitate toward specific agent selection for subsequent anticoagulation management. While rivaroxaban is an attractive oral therapy option, it is not an appropriate choice for patients with significant renal disease; patients with cancer are better treated with low molecular weight heparin when possible. Warfarin anticoagulation continues to be a well-known, valid, and cost-effective treatment option. At the end of the primary treatment we assess each patient for the likelihood of thromboembolism recurrence, which will be highest among those patients with idiopathic events or those with cancer-associated thrombosis. We favor prolonged anticoagulation in these scenarios. In addition, we strongly advocate periodic scheduled follow up of patients on long-term anticoagulation for secondary prophylaxis to re-evaluate their bleeding and recurrence risk. We understand both of these extremes are in a dynamic balance, and likewise so should be the anticoagulation directives. As we learn more about recurrence and bleeding prediction, we foresee a personalized approach in which the anticoagulant agent for each patient will be narrowly chosen based on their specific performance.
authors: Cardiovascular Medicine -Vascular Medicine, Oklahoma University Health and Sciences Center, 920 Stanton L Young Blvd. WP 3010, Oklahoma City, OK, 73104, USA.
authors: Omar
authors: O
authors: Esponda
authors: Alfonso
authors: A
authors: Tafur
references: Mayo Clin Proc. 2010 Sep;85(9):785-90
references: 20810792
references: Int J Vitam Nutr Res. 2006 Mar;76(2):65-74
references: 16941417
references: Ann Thorac Surg. 2012 Jul;94(1):104-8
references: 22542068
references: J Am Coll Nutr. 2000 Nov-Dec;19(6):801-7
references: 11194535
references: J Thromb Haemost. 2008 May;6(5):772-80
references: 18318689
references: N Engl J Med. 2003 Jul 10;349(2):146-53
references: 12853587
references: J Thromb Haemost. 2011 Dec;9(12):2389-96
references: 21883878
references: J Thromb Haemost. 2011 Oct;9(10):2115-7
references: 21848693
references: N Engl J Med. 2009 Dec 10;361(24):2342-52
references: 19966341
references: Blood. 2004 Jan 15;103(2):613-6
references: 14512301
references: Arch Intern Med. 1996 Apr 22;156(8):857-60
references: 8774204
references: Thromb Haemost. 2008 May;99(5):830-9
references: 18449412
references: Surg Endosc. 2013 May;27(5):1754-60
references: 23271270
references: Chest. 2002 Mar;121(3):877-905
references: 11888976
references: Circulation. 2011 Apr 26;123(16):1788-830
references: 21422387
references: J Thorac Cardiovasc Surg. 2005 May;129(5):1018-23
references: 15867775
references: Circulation. 2012 Jan 3;125(1):e2-e220
references: 22179539
references: Br J Clin Pharmacol. 2011 Oct;72(4):581-92
references: 21241354
references: Blood Rev. 2012 Jan;26(1):1-14
references: 21914559
references: Curr Treat Options Cardiovasc Med. 2005 Dec;7(6):483-90
references: 16283976
references: Transfus Apher Sci. 2012 Jun;46(3):309-14
references: 22503307
references: Am J Med. 2012 Jan;125(1):50-6
references: 22115025
references: Thromb Haemost. 2000 Mar;83(3):416-20
references: 10744147
references: Pharmacotherapy. 2006 Aug;26(8):1091-8
references: 16863486
references: Chest. 1995 Jan;107(1 Suppl):3S-9S
references: 7813326
references: J Thromb Haemost. 2010 Jun;8(6):1235-41
references: 20230418
references: Biologics. 2008 Sep;2(3):481-90
references: 19707378
references: Am J Cardiol. 2007 Feb 1;99(3):421-3
references: 17261411
references: J Vasc Interv Radiol. 2011 Nov;22(11):1507-12
references: 21903414
references: Fundam Clin Pharmacol. 2012 Feb;26(1):27-32
references: 21848931
references: Adv Ther. 2010 Sep;27(9):648-54
references: 20694805
references: N Engl J Med. 1998 Feb 12;338(7):409-15
references: 9459643
references: Circulation. 1999 Jan 5-12;99(1):73-80
references: 9884382
references: Am Heart J. 2009 Jun;157(6):1081-7
references: 19464420
references: Chest. 2012 Feb;141(2 Suppl):e24S-e43S
references: 22315264
references: Chest. 2006 Apr;129(4):1043-50
references: 16608956
references: J Vasc Access. 2008 Apr-Jun;9(2):102-10
references: 18609524
references: N Engl J Med. 2012 May 24;366(21):1959-67
references: 22621626
references: Blood. 2012 Nov 15;120(20):4160-7
references: 22990018
references: Circulation. 2004 Aug 10;110(6):744-9
references: 15262836
references: N Engl J Med. 2003 Oct 30;349(18):1695-702
references: 14585937
references: Eur J Cardiothorac Surg. 2012 Dec;42(6):951-7
references: 22491666
references: Ann Intern Med. 2006 Feb 7;144(3):165-71
references: 16461960
references: Thromb Res. 2012 Apr;129(4):418-25
references: 22119500
references: Ann Thorac Surg. 2012 Sep;94(3):785-91
references: 22698769
references: BMJ. 2012 Jun 06;344:e2985
references: 22674922
references: Pharmacotherapy. 2011 Sep;31(9):850-6
references: 21923585
references: Perspect Vasc Surg Endovasc Ther. 2007 Mar;19(1):78-84
references: 17437987
references: Am J Med. 2012 May;125(5):465-70
references: 22325236
references: Blood Coagul Fibrinolysis. 2010 Dec;21(8):758-63
references: 20885294
references: Chest. 2012 Feb;141(2 Suppl):e419S-e496S
references: 22315268
references: Haematologica. 2010 Dec;95(12):2088-94
references: 20801904
references: PLoS One. 2012;7(2):e30891
references: 22383978
references: Am J Cardiol. 2006 Feb 1;97(3):409-11
references: 16442406
references: Am Heart J. 2012 Jan;163(1):33-38.e1
references: 22172434
references: Thromb Haemost. 2012 Mar;107(3):485-93
references: 22318455
references: Arch Intern Med. 2002 Dec 9-23;162(22):2537-41
references: 12456225
references: J Thromb Haemost. 2011 Aug;9(8):1500-7
references: 21645235
references: J Vasc Interv Radiol. 2010 Jun;21(6):779-87
references: 20434365
references: Thromb Res. 2010 Mar;125(3):e82-6
references: 19833379
references: N Engl J Med. 2012 Apr 5;366(14):1287-97
references: 22449293
references: J Am Coll Cardiol. 1992 Jul;20(1):24-30
references: 1607532
references: Thromb Haemost. 2012 Sep;108(3):554-60
references: 22739999
references: Ann Intern Med. 2011 Nov 15;155(10):653-9, W201-3
references: 22084331
references: Ann Pharmacother. 2010 Apr;44(4):718-26
references: 20233918
references: N Engl J Med. 2012 Nov 22;367(21):1979-87
references: 23121403
references: Am J Epidemiol. 2012 Jan 15;175(2):114-26
references: 22180874
references: Chest. 2012 Feb;141(2 Suppl):e495S-e530S
references: 22315270
references: F1000 Med Rep. 2012;4:9
references: 22619694
references: Eur J Cardiothorac Surg. 2013 Jan;43(1):90-4; discussion 94
references: 22466693
references: Ann Intern Med. 2004 Apr 20;140(8):589-602
references: 15096330
references: Chest. 2012 Feb;141(2 Suppl):7S-47S
references: 22315257
references: World Neurosurg. 2013 Jan;79(1):154-8
references: 22722043
references: Circulation. 1988 Feb;77(2):353-60
references: 3123091
references: Vasc Health Risk Manag. 2008;4(3):629-36
references: 18827912
references: J Card Surg. 2005 May-Jun;20(3):289-90
references: 15854099
references: Clin Chest Med. 2010 Dec;31(4):611-28
references: 21047571
references: J Thorac Cardiovasc Surg. 2008 Aug;136(2):448-51
references: 18692656
references: J Thromb Thrombolysis. 2005 Jun;19(3):183-8
references: 16082605
references: Semin Respir Crit Care Med. 2012 Apr;33(2):186-90
references: 22648491